查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球Omega-3市场（按类型、来源、应用、形式、製造技术和地区划分）- 预测至 2030 年
市场调查报告书
商品编码
1845350

全球Omega-3市场（按类型、来源、应用、形式、製造技术和地区划分）- 预测至 2030 年

Omega-3 Market by Type, Source, Application, Form, Manufacturing Technology, and Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 314 Pages | 订单完成后即时交付

价格

预计 2025 年全球Omega-3市场规模为 43.622 亿美元，到 2030 年将达到 77.564 亿美元，复合年增长率为 12.2%。

调查范围
调查年份 2021-2030
基准年 2024
预测期 2025-2030
单元 100万美元，KT
部分 类型、原料、用途、形状、製造技术、地区
目标区域 北美、欧洲、亚太、南美和其他地区

随着人们日益意识到EPA和DHA在心血管健康、认知功能、视力、关节健康和婴儿大脑发育中的作用，以及消费者日益转向预防性保健和功能性营养，Omega-3市场正获得显着发展。婴儿奶粉市场呈现爆炸性成长，这得益于家长们对早期营养的重要性，尤其是DHA和其他必需营养素在认知和身体发育中的作用的认识不断提高，以及北美、欧洲和中国等地区颁布法规和建议，强製或鼓励在奶粉中添加DHA。然而，高昂的研发成本和波动的鱼油价格预计将对Omega-3市场的成长构成挑战。

Omega-3 市场-IMG1

Omega-3市场的动盪可能为企业创造机会

Omega-3市场正经历根本性变革，为企业带来新的机会。其中最大的变化之一是向永续的植物来源成分（例如藻油和发酵型Omega-3）的转变，这些成分解决了人们对鱼油供应的担忧，并引起了纯素食者和绿色消费者的共鸣。监管法规的更新，例如婴儿营养品中强制添加DHA以及心血管和认知健康声明的更广泛核准，也推动了已开发市场和新兴市场的稳定需求。同时，微胶囊化等技术进步正在提高Omega-3的稳定性和风味，使其能够被应用于新的食品和饮料领域。

在应用方面，除了传统的补充剂外， Omega-3在药品、宠物食品和水产养殖中的应用也日益广泛。用于神经系统和心血管健康的药用级配方发展势头强劲，而高端宠物食品和强化水产养殖饲料也呈现显着增长。这些趋势，加上方便食用的功能性营养产品（软糖、粉剂、即饮）的需求不断增长，以及拉丁美洲和亚太地区消费者在保健品上的支出不断增长，正在重新定义市场格局。对于在采购、产品开发和永续性方面不断创新的公司来说，在新兴市场中实现成长的机会无处不在。

营养补充品领域预计将成为成长最快的领域之一

随着消费者越来越重视预防保健，并寻求便利的心臟、大脑、眼睛和关节健康解决方案，膳食补充剂类别成为Omega-3市场的主要成长动力之一。在健康声明获得监管机构核准的支持下，补充剂不仅具有可靠性和便捷性，而且软胶囊、软糖和粉末等给药方式的进步也使其对各个年龄层的人群都具有吸引力。健康意识的增强、人口老化以及产品创新的协同作用，正在推动膳食补充剂中Omega-3的强劲且持续的需求。

液体Omega-3预计将占据Omega-3市场的很大份额

市面上大多数Omega-3来自鱼类、藻类和磷虾油，这些油呈液态，常用于膳食补充剂、婴儿奶粉、机能性食品和药品。液体 Omega-3 脂肪酸纯度更高，生物利用度更高，更容易融入软胶囊、乳剂和强化流质食品中。虽然干粉配方（粉末、微胶囊化Omega-3脂肪酸）因其在软糖、粉末和烘焙食品中的应用而日益普及，但液体 Omega-3 脂肪酸仍然占据着最大的市场份额，因为它们最具成本效益，可以大规模生产，并且在各个行业都很容易获得。

二十碳五烯酸（EPA）领域预计将显着成长

EPA已被证明有益于心臟健康，能够降低三酸甘油酯水平、减少发炎并改善整体心血管功能。随着消费者对这些健康益处的认识不断提高，对含有EPA的Omega-3补充剂以及强化食品和饮料的需求不断增长，从而促进了Omega-3市场的扩张。

本报告研究了全球Omega-3市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 主要发现

  • Omega-3市场为企业带来诱人机会
  • 北美Omega-3市场（按来源和国家划分）
  • 按类型分類的Omega-3市场
  • Omega-3市场的应用
  • 按来源和地区分類的Omega-3市场
  • Omega-3市场：区域概况

第五章 市场概况

  • 介绍
  • 总体经济指标
    • 预防性医疗支出
    • 老年人口不断增加
  • 市场动态
    • 驱动程式
    • 抑制因素
    • 机会
    • 任务
  • 产生的人工智慧对食品和饮料成分/添加剂的影响
    • 生成式人工智慧在食品和饮料配料/添加剂的应用
    • 食品和饮料配料/添加剂的生成式人工智慧案例研究
    • 人工智慧/生成式人工智慧对Omega-3市场的影响
    • 致力于产生人工智慧的邻近生态系统

第六章 产业趋势

  • 介绍
  • 2025年美国关税的影响 - Omega-3市场
    • 介绍
    • 主要关税税率
    • Omega-3市场的动盪
    • 价格影响分析
    • 对国家的影响
    • 对各种应用的影响
  • 价值链分析
    • 研究与产品开发
    • 采购
    • 生产加工
    • 分配
    • 行销和销售
    • 最终用户
  • 贸易分析
    • HS 代码 1504 的进口场景
    • HS 编码 1504 出口情景
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 定价分析
    • Omega-3最终产品（依产品类型）平均售价
    • 各地区平均销售价格趋势
  • 生态系分析
    • 需求端
    • 供应端
  • 影响客户业务的趋势/中断
  • 专利分析
  • 大型会议和活动（2025-2026）
  • 监管格局
    • 监管机构、政府机构和其他组织
    • 规定
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 案例研究分析
  • 投资金筹措场景

第七章Omega-3市场（按类型）

  • 介绍
  • 二十二碳六烯酸
  • 二十碳五烯酸
  • α-亚麻油酸

第八章Omega-3市场（依来源）

  • 介绍
  • 海洋
  • 植物

第九章Omega-3市场应用

  • 介绍
  • 营养补充品
  • 机能性食品和饮料
  • 製药
  • 婴儿奶粉
  • 宠物食品和饲料

第 10 章Omega-3市场（按形态）

  • 介绍
  • 烘干
  • 液体

第 11 章Omega-3市场（依製造技术）

  • 介绍
  • 萃取
    • 精炼和净化
    • 浓缩和转化
    • 封装和稳定
    • 发酵与生物技术

第 12 章Omega-3市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 挪威
    • 义大利
    • 西班牙
    • 荷兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲和纽西兰
    • 其他亚太地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 其他地区
    • 非洲
    • 中东

第十三章竞争格局

  • 概述
  • 主要参与企业的策略/优势（2020-2024）
  • 收益分析
  • 市占率分析
  • 公司估值及财务指标
  • 品牌/产品比较
  • 企业评估矩阵：主要企业（2024年）
  • 公司评估矩阵：Start-Ups/中小企业（2024 年）
  • 竞争场景

第十四章：公司简介

  • 主要企业
    • DSM-FIRMENICH
    • CARGILL, INCORPORATED
    • BASF SE
    • ADM
    • KERRY GROUP PLC
    • CORBION
    • KD PHARMA GROUP SA
    • AKER BIOMARINE
    • CRODA INTERNATIONAL PLC
    • EVONIK INDUSTRIES AG
    • PELAGIA AS
    • GC RIEBER
    • COOKE AQUACULTURE INC.
    • ALGISYS BIOSCIENCES, INC.
    • POLARIS
  • 其他公司
    • BTSA
    • NOVOSANA EUROPE BV
    • GOLDEN OMEGA
    • KINOMEGA BIOPHARM INC.
    • RIMFROST AS
    • ALGARITHM
    • SOLUTEX
    • CELLANA INC.
    • SINOMEGA BIOTECH ENGINEERING CO., LTD.
    • ALGAECYTES LIMITED

第十五章：邻近市场与相关市场

  • 介绍
  • 研究局限性
  • 机能性食品配料市场
    • 市场定义
    • 市场概况
  • 胶原蛋白市场
    • 市场定义
    • 市场概况

第十六章 附录

Product Code: FB 2759

The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2%.

Scope of the Report
Years Considered for the Study2021-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million) and Volume (KT)
SegmentsType, source, application, form, manufacturing technology, and region
Regions coveredNorth America, Europe, Asia Pacific, South America, and Rest of the World (RoW)

The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market's growth.

Omega-3 Market - IMG1

Disruptions in the omega-3 market may offer opportunities for players

The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.

On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.

The dietary supplement segment is projected to be one of the fastest-growing segments

The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.

The liquid form of omega-3 is expected to hold a larger share of the omega-3 market

The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated Omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.

The Eicosapentaenoic Acid (EPA) segment is expected to grow at a significant rate

The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.

The US is estimated to dominate the North American omega-3 market during the forecast period

The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.

  • By Company Type: Tier 1-25%, Tier 2-45%, and Tier 3-30%
  • By Designation: CXOs-25%, Managers-40%, Executives-35%
  • By Region: North America-22%, Europe-28%, Asia Pacific-32%, South America-10% and Rest of the World-8%

Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others.

Research Coverage

This research report categorizes the omega-3 market by type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.

Reasons to Buy This Report

The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
  • Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
  • Market Development: Comprehensive information about lucrative markets-the report analyzes omega-3 across varied regions
  • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary profiles
      • 2.1.2.3 Key insights from industry experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOP-DOWN APPROACH
    • 2.2.2 SUPPLY-SIDE ANALYSIS
    • 2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
  • 2.3 DATA TRIANGULATION AND MARKET BREAKUP
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
  • 4.2 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE AND COUNTRY
  • 4.3 OMEGA-3 MARKET, BY TYPE
  • 4.4 OMEGA-3 MARKET, BY APPLICATION
  • 4.5 OMEGA-3 MARKET, BY SOURCE AND REGION
  • 4.6 OMEGA-3 MARKET: REGIONAL SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE
    • 5.2.2 GROWING GERIATRIC POPULATION
  • 5.3 MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growing consumer awareness regarding health benefits
      • 5.3.1.2 Increasing use in food and feed products
        • 5.3.1.2.1 Rising demand for mother and infant nutrition products
        • 5.3.1.2.2 Mandatory inclusion of algal DHA in infant formula
        • 5.3.1.2.3 Growth focus of food processing companies on fortification
        • 5.3.1.2.4 Increasing applications in pet food and feed
      • 5.3.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets
      • 5.3.1.4 Emergence of innovative production technologies
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Declining fish oil supply due to sustainability issues in fisheries
      • 5.3.2.2 Lack of clarity on daily intake recommendations and health claims
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Increasing research on alternative sources
        • 5.3.3.1.1 Rising consumer demand for plant-based products
        • 5.3.3.1.2 Growing focus on microalgae-based omega-3 production
        • 5.3.3.1.3 Side effects and allergies related to fish-based products
      • 5.3.3.2 Favorable regulatory environment
      • 5.3.3.3 Integration of microencapsulation technology
    • 5.3.4 CHALLENGES
      • 5.3.4.1 High costs involved in R&D activities
      • 5.3.4.2 Volatility in fish oil prices
      • 5.3.4.3 Instability of omega-3 oils
  • 5.4 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES
    • 5.4.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
    • 5.4.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
      • 5.4.2.1 Kerry Trendspotter leveraged AI and ML to analyze consumer-generated social media content, identifying and predicting food trends
      • 5.4.2.2 IFF partners with Salus Optima to create personalized nutrition platform using AI to offer customized dietary recommendations based on metabolic health
      • 5.4.2.3 Ingredion utilized cloud-based data analytics, AI, and cloud technology to address challenges in F&B industry
    • 5.4.3 IMPACT OF AI/GENERATIVE AI ON OMEGA-3 MARKET
    • 5.4.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 IMPACT OF 2025 US TARIFF - OMEGA-3 MARKET
    • 6.2.1 INTRODUCTION
    • 6.2.2 KEY TARIFF RATES
    • 6.2.3 DISRUPTION IN OMEGA-3 MARKET
    • 6.2.4 PRICE IMPACT ANALYSIS
    • 6.2.5 IMPACT ON COUNTRY/REGION
      • 6.2.5.1 US
      • 6.2.5.2 Europe
      • 6.2.5.3 China
    • 6.2.6 IMPACT ON DIFFERENT APPLICATIONS
  • 6.3 VALUE CHAIN ANALYSIS
    • 6.3.1 RESEARCH AND PRODUCT DEVELOPMENT
    • 6.3.2 SOURCING
    • 6.3.3 PRODUCTION AND PROCESSING
    • 6.3.4 DISTRIBUTION
    • 6.3.5 MARKETING AND SALES
    • 6.3.6 END USERS
  • 6.4 TRADE ANALYSIS
    • 6.4.1 IMPORT SCENARIO OF HS CODE 1504
    • 6.4.2 EXPORT SCENARIO OF HS CODE 1504
  • 6.5 TECHNOLOGY ANALYSIS
    • 6.5.1 KEY TECHNOLOGIES
      • 6.5.1.1 Molecular distillation
      • 6.5.1.2 Supercritical CO2 extraction
      • 6.5.1.3 Algae fermentation
    • 6.5.2 COMPLEMENTARY TECHNOLOGIES
      • 6.5.2.1 Stabilization & antioxidant technologies
      • 6.5.2.2 Microencapsulation
    • 6.5.3 ADJACENT TECHNOLOGIES
      • 6.5.3.1 Precision fermentation
      • 6.5.3.2 Synthetic biology & bioprocess engineering
  • 6.6 PRICING ANALYSIS
    • 6.6.1 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE
    • 6.6.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 6.7 ECOSYSTEM ANALYSIS
    • 6.7.1 DEMAND SIDE
    • 6.7.2 SUPPLY SIDE
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.9 PATENT ANALYSIS
  • 6.10 KEY CONFERENCES AND EVENTS, 2025-2026
  • 6.11 REGULATORY LANDSCAPE
    • 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.11.2 REGULATIONS
      • 6.11.2.1 North America
        • 6.11.2.1.1 US
        • 6.11.2.1.2 Canada
      • 6.11.2.2 Europe
      • 6.11.2.3 Asia Pacific
        • 6.11.2.3.1 China
        • 6.11.2.3.2 Japan
        • 6.11.2.3.3 India
      • 6.11.2.4 South America
        • 6.11.2.4.1 Brazil
        • 6.11.2.4.2 Argentina
        • 6.11.2.4.3 Chile
      • 6.11.2.5 Rest of the World
        • 6.11.2.5.1 South Africa
        • 6.11.2.5.2 UAE
  • 6.12 PORTER'S FIVE FORCES ANALYSIS
    • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.12.2 BARGAINING POWER OF SUPPLIERS
    • 6.12.3 BARGAINING POWER OF BUYERS
    • 6.12.4 THREAT OF SUBSTITUTES
    • 6.12.5 THREAT OF NEW ENTRANTS
  • 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.13.2 BUYING CRITERIA
  • 6.14 CASE STUDY ANALYSIS
    • 6.14.1 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE
    • 6.14.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
    • 6.14.3 AKER BIOMARINE SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
  • 6.15 INVESTMENT AND FUNDING SCENARIO

7 OMEGA-3 MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030 - USD MILLION)

  • 7.1 INTRODUCTION
  • 7.2 DOCOSAHEXAENOIC ACID
    • 7.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND
  • 7.3 EICOSAPENTAENOIC ACID
    • 7.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
  • 7.4 ALPHA-LINOLENIC ACID
    • 7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND

8 OMEGA-3 MARKET, BY SOURCE (MARKET SIZE & FORECAST TO 2030- USD MILLION & KILOTONS)

  • 8.1 INTRODUCTION
  • 8.2 MARINE
    • 8.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET
    • 8.2.2 FISH
      • 8.2.2.1 Anchovy
      • 8.2.2.2 Sardine
      • 8.2.2.3 Mackerel
      • 8.2.2.4 Other fish types
    • 8.2.3 ALGAE
      • 8.2.3.1 Schizochytrium sp.
      • 8.2.3.2 Crypthecodinium cohnii
      • 8.2.3.3 Nannochloropsis sp.
      • 8.2.3.4 Other algae types
    • 8.2.4 KRILL
    • 8.2.5 OTHER MARINE SOURCES
  • 8.3 PLANT
    • 8.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND
    • 8.3.2 NUTS & SEEDS
    • 8.3.3 VEGETABLE OILS

9 OMEGA-3 MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2030 - USD MILLION)

  • 9.1 INTRODUCTION
  • 9.2 DIETARY SUPPLEMENTS
    • 9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND
  • 9.3 FUNCTIONAL FOODS & BEVERAGES
    • 9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
    • 9.3.2 DAIRY & DAIRY ALTERNATIVES
    • 9.3.3 BAKERY & CEREAL PRODUCTS
    • 9.3.4 CONFECTIONERY PRODUCTS
    • 9.3.5 MEAT & MEAT PRODUCTS
    • 9.3.6 BEVERAGES
    • 9.3.7 OTHER FUNCTIONAL FOOD PRODUCTS
  • 9.4 PHARMACEUTICALS
    • 9.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
  • 9.5 INFANT FORMULAS
    • 9.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
  • 9.6 PET FOOD & FEED
    • 9.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET
    • 9.6.2 PET FOOD
    • 9.6.3 ANIMAL FEED

10 OMEGA-3 MARKET, BY FORM (MARKET SIZE & FORECAST TO 2030 - USD MILLION)

  • 10.1 INTRODUCTION
  • 10.2 DRY
    • 10.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS
  • 10.3 LIQUID
    • 10.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND

11 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY

  • 11.1 INTRODUCTION
  • 11.2 EXTRACTION
    • 11.2.1 REFINING & PURIFICATION
    • 11.2.2 CONCENTRATION & CONVERSION
    • 11.2.3 ENCAPSULATION & STABILIZATION
    • 11.2.4 FERMENTATION & BIOTECHNOLOGY

12 OMEGA-3 MARKET, BY REGION (MARKET SIZE & FORECAST TO 2030 - USD MILLION & KILOTONS)

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing application in functional foods & beverages to boost market
    • 12.2.3 MEXICO
      • 12.2.3.1 Growing focus on heart disease prevention to drive market
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Low fish consumption to boost demand for omega-3-based supplements
    • 12.3.2 UK
      • 12.3.2.1 Increasing focus on preventive healthcare and maintaining cognitive function into older age to drive market
    • 12.3.3 FRANCE
      • 12.3.3.1 Ongoing innovations to boost quality and stability of omega-3-rich oil formulation to drive market
    • 12.3.4 NORWAY
      • 12.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players
    • 12.3.5 ITALY
      • 12.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market
    • 12.3.6 SPAIN
      • 12.3.6.1 Rising consumer awareness and dietary gaps to drive market
    • 12.3.7 NETHERLANDS
      • 12.3.7.1 Growing incidences of depression, autism, and ADHD to drive market
    • 12.3.8 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Increasing focus on product innovations and diversification to drive market
    • 12.4.2 INDIA
      • 12.4.2.1 Growing incidences of heart failure to drive market
    • 12.4.3 JAPAN
      • 12.4.3.1 Rising use of innovative formulation technology to create opportunities for omega-3 product manufacturers
    • 12.4.4 AUSTRALIA & NEW ZEALAND
      • 12.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
    • 12.4.5 REST OF ASIA PACIFIC
  • 12.5 SOUTH AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Rising demand for algal oils to drive market
    • 12.5.2 ARGENTINA
      • 12.5.2.1 Commercialization of omega-3 products to fuel market
    • 12.5.3 REST OF SOUTH AMERICA
  • 12.6 REST OF THE WORLD
    • 12.6.1 AFRICA
      • 12.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market
    • 12.6.2 MIDDLE EAST
      • 12.6.2.1 Ongoing innovations in omega-3 products to drive market

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
  • 13.3 REVENUE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.6 BRAND/PRODUCT COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.7.5.1 Company footprint
      • 13.7.5.2 Regional footprint
      • 13.7.5.3 Source footprint
      • 13.7.5.4 Type footprint
      • 13.7.5.5 Application footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 13.8.5.1 Detailed list of key startups/SMEs
      • 13.8.5.2 Competitive benchmarking of key startups/SMEs
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 DSM-FIRMENICH
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product launches and enhancements
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 CARGILL, INCORPORATED
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 BASF SE
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 MnM view
        • 14.1.3.3.1 Key strengths
        • 14.1.3.3.2 Strategic choices
        • 14.1.3.3.3 Weaknesses and competitive threats
    • 14.1.4 ADM
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Right to win
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 KERRY GROUP PLC
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Deals
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Right to win
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 CORBION
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product launches and enhancements
        • 14.1.6.3.2 Expansions
        • 14.1.6.3.3 Other developments
      • 14.1.6.4 MnM view
    • 14.1.7 KD PHARMA GROUP SA
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
        • 14.1.7.3.2 Expansions
      • 14.1.7.4 MnM view
    • 14.1.8 AKER BIOMARINE
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches and enhancements
        • 14.1.8.3.2 Deals
        • 14.1.8.3.3 Other developments
      • 14.1.8.4 MnM view
    • 14.1.9 CRODA INTERNATIONAL PLC
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Solutions/Services offered
      • 14.1.9.3 MnM view
    • 14.1.10 EVONIK INDUSTRIES AG
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Solutions/Services offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Product launches and enhancements
        • 14.1.10.3.2 Deals
      • 14.1.10.4 MnM view
    • 14.1.11 PELAGIA AS
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products/Solutions/Services offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Product launches and enhancements
        • 14.1.11.3.2 Other developments
      • 14.1.11.4 MnM view
    • 14.1.12 GC RIEBER
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products/Solutions/Services offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Product launches and enhancements
        • 14.1.12.3.2 Deals
        • 14.1.12.3.3 Expansions
      • 14.1.12.4 MnM view
    • 14.1.13 COOKE AQUACULTURE INC.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products/Solutions/Services offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Deals
      • 14.1.13.4 MnM view
    • 14.1.14 ALGISYS BIOSCIENCES, INC.
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products/Solutions/Services offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Other developments
      • 14.1.14.4 MnM view
    • 14.1.15 POLARIS
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products/Solutions/Services offered
      • 14.1.15.3 Recent developments
        • 14.1.15.3.1 Product launches and enhancements
        • 14.1.15.3.2 Other developments
      • 14.1.15.4 MnM view
  • 14.2 OTHER PLAYERS
    • 14.2.1 BTSA
      • 14.2.1.1 Business overview
      • 14.2.1.2 Products/Solutions/Services offered
      • 14.2.1.3 MnM view
    • 14.2.2 NOVOSANA EUROPE B.V.
      • 14.2.2.1 Business overview
      • 14.2.2.2 Products/Solutions/Services offered
      • 14.2.2.3 Recent developments
        • 14.2.2.3.1 Deals
      • 14.2.2.4 MnM view
    • 14.2.3 GOLDEN OMEGA
      • 14.2.3.1 Business overview
      • 14.2.3.2 Products/Solutions/Services offered
      • 14.2.3.3 Recent developments
        • 14.2.3.3.1 Deals
      • 14.2.3.4 MnM view
    • 14.2.4 KINOMEGA BIOPHARM INC.
      • 14.2.4.1 Business overview
      • 14.2.4.2 Products/Solutions/Services offered
      • 14.2.4.3 MnM view
    • 14.2.5 RIMFROST AS
      • 14.2.5.1 Business overview
      • 14.2.5.2 Products/Solutions/Services offered
      • 14.2.5.3 Recent developments
        • 14.2.5.3.1 Deals
      • 14.2.5.4 MnM view
    • 14.2.6 ALGARITHM
    • 14.2.7 SOLUTEX
    • 14.2.8 CELLANA INC.
    • 14.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD.
    • 14.2.10 ALGAECYTES LIMITED

15 ADJACENT & RELATED MARKETS

  • 15.1 INTRODUCTION
  • 15.2 STUDY LIMITATIONS
  • 15.3 FUNCTIONAL FOOD INGREDIENTS MARKET
    • 15.3.1 MARKET DEFINITION
    • 15.3.2 MARKET OVERVIEW
  • 15.4 COLLAGEN MARKET
    • 15.4.1 MARKET DEFINITION
    • 15.4.2 MARKET OVERVIEW

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 USD EXCHANGE RATES, 2020-2024
  • TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2025 VS. 2030 (USD MILLION)
  • TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
  • TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM)
  • TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS
  • TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
  • TABLE 7 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 8 EXPECTED IMPACT LEVEL ON RAW MATERIALS AND INGREDIENTS WITH RELEVANT HS CODES DUE TO US TARIFF IMPACT
  • TABLE 9 OMEGA-3 MARKET: EXPECTED TARIFF IMPACT ON APPLICATIONS
  • TABLE 10 IMPORT SCENARIO FOR HS CODE: 1504, BY COUNTRY, 2020-2024 (TONS)
  • TABLE 11 EXPORT SCENARIO FOR HS CODE: 1504, BY COUNTRY, 2020-2024 (TONS)
  • TABLE 12 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2024 (USD)
  • TABLE 13 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY REGION, 2021-2024 (USD/TON)
  • TABLE 14 OMEGA-3 MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 15 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET, 2022-2025
  • TABLE 16 OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 IMPACT OF PORTER'S FIVE FORCES ON OMEGA-3 MARKET
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS
  • TABLE 24 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS
  • TABLE 25 OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 26 OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 27 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
  • TABLE 28 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 29 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 30 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
  • TABLE 31 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 32 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
  • TABLE 34 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 35 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 36 OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 37 OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 38 OMEGA-3 MARKET, BY SOURCE, 2021-2024 (KILOTONS)
  • TABLE 39 OMEGA-3 MARKET, BY SOURCE, 2025-2030 (KILOTONS)
  • TABLE 40 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
  • TABLE 41 MARINE: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 42 MARINE: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43 MARINE: OMEGA-3 MARKET, BY REGION, 2021-2024 (KILOTONS)
  • TABLE 44 MARINE: OMEGA-3 MARKET, BY REGION, 2025-2030 (KILOTONS)
  • TABLE 45 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 46 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 47 FISH: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 48 FISH: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49 ALGAE: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 50 ALGAE: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51 KRILL: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 52 KRILL: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53 OTHER MARINE SOURCES: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 54 OTHER MARINE SOURCES: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55 PLANT: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 56 PLANT: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57 PLANT: OMEGA-3 MARKET, BY REGION, 2021-2024 (KILOTONS)
  • TABLE 58 PLANT: OMEGA-3 MARKET, BY REGION, 2025-2030 (KILOTONS)
  • TABLE 59 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 60 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 61 NUTS & SEEDS: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 62 NUTS & SEEDS: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63 VEGETABLE OILS: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 64 VEGETABLE OILS: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65 OMEGA-3 MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 66 OMEGA-3 MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67 DIETARY SUPPLEMENTS: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 68 DIETARY SUPPLEMENTS: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69 FUNCTIONAL FOODS & BEVERAGES: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 70 FUNCTIONAL FOODS & BEVERAGES: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71 PHARMACEUTICALS: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 72 PHARMACEUTICALS: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73 INFANT FORMULAS: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 74 INFANT FORMULAS: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75 PET FOOD & FEED: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 76 PET FOOD & FEED: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77 OMEGA-3 MARKET, BY FORM, 2021-2024 (USD MILLION)
  • TABLE 78 OMEGA-3 MARKET, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 79 DRY: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 80 DRY: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81 LIQUID: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 82 LIQUID: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83 OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 84 OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85 OMEGA-3 MARKET, BY REGION, 2021-2024 (KILOTONS)
  • TABLE 86 OMEGA-3 MARKET, BY REGION, 2025-2030 (KILOTONS)
  • TABLE 87 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 88 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 90 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 92 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 94 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (KILOTONS)
  • TABLE 96 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (KILOTONS)
  • TABLE 97 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 98 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 100 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 101 US: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 102 US: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 103 US: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 104 US: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 105 CANADA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 106 CANADA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 107 CANADA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 108 CANADA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 109 MEXICO: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 110 MEXICO: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 111 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 112 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 113 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 114 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 115 EUROPE: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 116 EUROPE: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 117 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 118 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 119 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 120 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 121 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (KILOTONS)
  • TABLE 122 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (KILOTONS)
  • TABLE 123 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 124 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 125 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 126 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 127 GERMANY: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 128 GERMANY: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 129 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 130 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 131 UK: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 132 UK: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 133 UK: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 134 UK: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 135 FRANCE: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 136 FRANCE: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 137 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 138 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 139 NORWAY: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 140 NORWAY: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 141 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 142 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 143 ITALY: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 144 ITALY: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 145 ITALY: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 146 ITALY: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 147 SPAIN: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 148 SPAIN: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 149 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 150 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 152 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 153 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 154 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (KILOTONS)
  • TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (KILOTONS)
  • TABLE 169 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 174 CHINA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 176 CHINA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 177 INDIA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 178 INDIA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 179 INDIA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 180 INDIA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 181 JAPAN: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 182 JAPAN: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 183 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 184 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 185 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 186 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 187 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 188 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 189 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 190 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 191 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 192 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 193 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 194 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 195 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 196 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 197 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 198 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 200 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 201 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (KILOTONS)
  • TABLE 202 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (KILOTONS)
  • TABLE 203 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 204 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 205 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 206 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 207 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 208 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 209 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 210 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 211 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 212 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 213 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 214 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 215 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 216 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 217 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 218 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 219 REST OF THE WORLD: OMEGA-3 MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 220 REST OF THE WORLD: OMEGA-3 MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 221 REST OF THE WORLD: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 222 REST OF THE WORLD: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 223 REST OF THE WORLD: OMEGA-3 MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 224 REST OF THE WORLD: OMEGA-3 MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 226 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 227 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (KILOTONS)
  • TABLE 228 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (KILOTONS)
  • TABLE 229 REST OF THE WORLD: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 230 REST OF THE WORLD: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 231 REST OF THE WORLD: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2021-2024 (USD MILLION)
  • TABLE 232 REST OF THE WORLD: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233 AFRICA: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 234 AFRICA: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 235 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 236 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 237 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 238 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 239 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2021-2024 (USD MILLION)
  • TABLE 240 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS, 2020-2024
  • TABLE 242 OMEGA-3 MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 243 OMEGA-3 MARKET: REGIONAL FOOTPRINT
  • TABLE 244 OMEGA-3 MARKET: SOURCE FOOTPRINT
  • TABLE 245 OMEGA-3 MARKET: TYPE FOOTPRINT
  • TABLE 246 OMEGA-3 MARKET: APPLICATION FOOTPRINT
  • TABLE 247 OMEGA-3 MARKET: KEY STARTUPS/SMES
  • TABLE 248 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 249 OMEGA-3 MARKET: PRODUCT LAUNCHES AND ENHANCEMENTS, 2020-AUGUST 2025
  • TABLE 250 OMEGA-3 MARKET: DEALS, 2020-AUGUST 2025
  • TABLE 251 OMEGA-3 MARKET: EXPANSIONS, 2020-AUGUST 2025
  • TABLE 252 DSM-FIRMENICH: COMPANY OVERVIEW
  • TABLE 253 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 254 DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 255 CARGILL, INCORPORATED: COMPANY OVERVIEW
  • TABLE 256 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 257 CARGILL, INCORPORATED: DEALS
  • TABLE 258 BASF SE: COMPANY OVERVIEW
  • TABLE 259 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 260 ADM: COMPANY OVERVIEW
  • TABLE 261 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 262 KERRY GROUP PLC: COMPANY OVERVIEW
  • TABLE 263 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 264 KERRY GROUP PLC: DEALS
  • TABLE 265 CORBION: COMPANY OVERVIEW
  • TABLE 266 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 267 CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 268 CORBION: EXPANSIONS
  • TABLE 269 CORBION: OTHER DEVELOPMENTS
  • TABLE 270 KD PHARMA GROUP SA: COMPANY OVERVIEW
  • TABLE 271 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 272 KD PHARMA GROUP SA: DEALS
  • TABLE 273 KD PHARMA GROUP SA: EXPANSIONS
  • TABLE 274 AKER BIOMARINE: COMPANY OVERVIEW
  • TABLE 275 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 276 AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 277 AKER BIOMARINE: DEALS
  • TABLE 278 AKER BIOMARINE: OTHER DEVELOPMENTS
  • TABLE 279 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
  • TABLE 280 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 281 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
  • TABLE 282 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 283 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 284 EVONIK INDUSTRIES AG: DEALS
  • TABLE 285 PELAGIA AS: COMPANY OVERVIEW
  • TABLE 286 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 287 PELAGIA AS: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 288 PELAGIA AS: OTHER DEVELOPMENTS
  • TABLE 289 GC RIEBER: COMPANY OVERVIEW
  • TABLE 290 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 291 GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 292 GC REIBER: DEALS
  • TABLE 293 GC RIEBER: EXPANSIONS
  • TABLE 294 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
  • TABLE 295 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 296 COOKE AQUACULTURE INC.: DEALS
  • TABLE 297 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 298 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 299 ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS
  • TABLE 300 POLARIS: COMPANY OVERVIEW
  • TABLE 301 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 302 POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 303 POLARIS: OTHER DEVELOPMENTS
  • TABLE 304 BTSA: COMPANY OVERVIEW
  • TABLE 305 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 306 NOVOSANA EUROPE B.V.: COMPANY OVERVIEW
  • TABLE 307 NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 308 NOVOSANA EUROPE B.V.: DEALS
  • TABLE 309 GOLDEN OMEGA: COMPANY OVERVIEW
  • TABLE 310 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 311 GOLDEN OMEGA: DEALS
  • TABLE 312 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
  • TABLE 313 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 314 RIMFROST AS: COMPANY OVERVIEW
  • TABLE 315 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 316 RIMFROST AS: DEALS
  • TABLE 317 MARKETS ADJACENT TO OMEGA-3 MARKET
  • TABLE 318 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2019-2023 (USD MILLION)
  • TABLE 319 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 320 COLLAGEN MARKET, BY FORM, 2019-2022 (USD MILLION)
  • TABLE 321 COLLAGEN MARKET, BY FORM, 2023-2030 (USD MILLION)

List of Figures

  • FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
  • FIGURE 5 OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6 DATA TRIANGULATION
  • FIGURE 7 OMEGA-3 MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 8 OMEGA-3 MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 9 OMEGA-3 MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 10 OMEGA-3 MARKET SHARE AND GROWTH RATE, BY REGION, 2025 (VALUE)
  • FIGURE 11 RISING HEALTH AWARENESS AND PREVENTIVE NUTRITION TO DRIVE MARKET
  • FIGURE 12 MARINE SEGMENT AND US TO ACCOUNT FOR LARGEST MARKET SHARES IN NORTH AMERICA IN 2025
  • FIGURE 13 DHA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 14 DIETARY SUPPLEMENTS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 15 MARINE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 16 US TO RECORD LARGEST MARKET SHARE IN 2025
  • FIGURE 17 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2022
  • FIGURE 18 GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2014-2024
  • FIGURE 19 OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
  • FIGURE 21 MICROALGAE PROCESSING FOR OMEGA-3
  • FIGURE 22 ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS
  • FIGURE 23 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 24 IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2020-2024 (TONS)
  • FIGURE 25 EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2020-2024 (TONS)
  • FIGURE 26 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2024 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY REGION, 2021-2024 (USD/TON)
  • FIGURE 28 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 30 KEY PATENTS APPLIED AND GRANTED, 2015-2025
  • FIGURE 31 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET, 2015-2025
  • FIGURE 32 OMEGA-3 MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS
  • FIGURE 34 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS
  • FIGURE 35 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING
  • FIGURE 36 OMEGA-3 MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 37 OMEGA-3 MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 38 OMEGA-3 MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 39 OMEGA-3 MARKET, BY FORM, 2025 VS. 2030 (USD MILLION)
  • FIGURE 40 INDIA TO RECORD HIGHEST GROWTH RATE IN OMEGA-3 MARKET
  • FIGURE 41 NORTH AMERICA: REGIONAL SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: REGIONAL SNAPSHOT
  • FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2022-2024 (USD BILLION)
  • FIGURE 44 SHARE ANALYSIS OF OMEGA-3 MARKET, 2024
  • FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET
  • FIGURE 46 EV/EBITDA OF MAJOR PLAYERS
  • FIGURE 47 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 48 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 49 OMEGA-3 MARKET: COMPANY FOOTPRINT
  • FIGURE 50 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 51 DSM-FIRMENICH: COMPANY SNAPSHOT
  • FIGURE 52 CARGILL, INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 53 BASF SE: COMPANY SNAPSHOT
  • FIGURE 54 ADM: COMPANY SNAPSHOT
  • FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 56 CORBION: COMPANY SNAPSHOT
  • FIGURE 57 AKER BIOMARINE: COMPANY SNAPSHOT
  • FIGURE 58 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
  • FIGURE 59 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
  • FIGURE 60 PELAGIA AS: COMPANY SNAPSHOT
  • FIGURE 61 GC RIEBER: COMPANY SNAPSHOT